申请人:Zinser Hartmut
公开号:US20070219378A1
公开(公告)日:2007-09-20
Sodium fosphenytoin, 5,5-diphenyl-3-[(phosphonooxy)methyl]imidazolidine-2,4-dione disodium salt, a known anticonvulsive, antiepileptic and antiarrhythmic, can be prepared by reacting 3-hydroxymethyl-5,5-diphenylimidazoline-2,4-dione with a phosphorous acid diester or triester activated by an oxidizing agent, whose ester groups can be selectively cleaved from the reaction product, cleaving the ester groups from the resulting phosphoric acid diester 2,5-dioxo-4,4-diphenyl-imidazolidin-1-ylmethyl ester and converting the resulting 5,5-diphenyl-3-[(phosphonooxy)methyl]imidazolidine-2,4-dione to its disodium salt. The oxidizing agent is advantageously a halogenating agent such as elemental bromine or N-bromosuccinimide, and the phosphorous acid ester used is advantageously dibenzyl phosphite. Of particular importance—even taken on its own—is the fact that a phosphoric acid diester 2,5-dioxo-4,4-diphenylimidazolidin-1-ylmethyl ester, whose phosphoric acid diester structural element can be selectively cleaved, can be converted to 5,5-diphenyl-3-[(phosphonooxy)methyl]imidazolidine-2,4-dione and the latter converted to its disodium salt in a single operation.
磷酸盐
酯类活化剂反应3-羟甲基-5,5-二苯基
咪唑啉-2,4-二酮,制备出已知的抗惊厥、抗癫痫和
抗心律失常药物,即5,5
-二苯基-3-[(
磷酸酯氧基)甲基]
咪唑啉-2,4-二酮二钠盐。其酯基可以从反应产物中选择性地裂解,使得2,5-二氧代-4,4-二苯基
咪唑啉-1-基甲酯
磷酸盐酯的酯基被裂解,从而得到5,5
-二苯基-3-[(
磷酸酯氧基)甲基]
咪唑啉-2,4-二酮,再将其转化为二钠盐。优选的氧化剂是卤化剂,如元素
溴或N-
溴代琥珀
酰亚胺,优选的
磷酸盐酯是
二苯甲基膦酸酯。特别重要的是,可以通过单步操作将可以选择性裂解
磷酸二酯结构元素的2,5-二氧代-4,4-二苯基
咪唑啉-1-基甲酯
磷酸盐酯转化为5,5
-二苯基-3-[(
磷酸酯氧基)甲基]
咪唑啉-2,4-二酮,然后将其转化为二钠盐。